| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.59 | 2e-06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.26 | 9e-05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |